15 employees
N-Of-One analyzes and interprets tumor molecular profiles to help physicians and patients identify diagnostic and treatment strategies.
2008
$7M
from 2 investors over 2 rounds
N-of-One Therapeutics raised $7M on July 21, 2016
Investors: Excel Venture Management, LLC and Providence Ventures